Old Web
English
Sign In
Acemap
>
authorDetail
>
Carrie Condon
Carrie Condon
Medicine
Randomized controlled trial
Oncology
Internal medicine
Pathology
3
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 3, open-label, multicenter, randomized study to investigate the efficacy and safety of tislelizumab, an anti-PD-1 antibody, versus docetaxel in patients with non-small cell lung cancer who have progressed on a prior platinum-containing regimen.
2018
Journal of Clinical Oncology
Dingzhi Huang
Ziping Wang
Xinmin Yu
Ying Cheng
Jie Wang
Yun Fan
Zhiyong Ma
Jianhua Shi
Yan Yu
Yi Hu
James Song
Fan Xia
Zhirong Shen
Yun Zhang
Yingying Xu
Carrie Condon
Fangniu Shi
Yunfei Zhou
Andrea Pirzkall
Caicun Zhou
Show All
Source
Cite
Save
Citations (0)
FRESCO: A phase 2, randomized study of duvelisib plus rituximab vs R-CHOP in patients with relapsed/refractory follicular lymphoma who have progressed within 24 months of receiving an alkylator-based chemotherapy regimen.
2016
Journal of Clinical Oncology
Nathan Fowler
Joseph Pearlberg
Les H. Brail
Weiliang Shi
Liewen Jiang
Carrie Condon
Mathias Rummel
Show All
Source
Cite
Save
Citations (4)
ACE-536 Increases Hemoglobin and Decreases Transfusion Burden and Serum Ferritin in Adults with Beta-Thalassemia: Preliminary Results from a Phase 2 Study
2014
Blood
Antonio Piga
Silverio Perrotta
Angela Melpignano
Caterina Borgna Pignatti
Ersi Voskaridou
Vincenzo Caruso
Aldo Filosa
Yesim Aydinok
Carrie Condon
Dawn Wilson
Adberrahmane Laadem
Matthew L. Sherman
Kenneth M. Attie
Show All
Source
Cite
Save
Citations (10)
1